TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Craneware ( (GB:CRW) ) just unveiled an announcement.
Craneware plc has updated its issued share capital following recent employee share option exercises, resulting in 35,431,867 Ordinary Shares with voting rights. This change in share capital is significant for shareholders as it affects calculations related to their interests under the FCA’s Disclosure Guidance and Transparency Rules.
The most recent analyst rating on (GB:CRW) stock is a Hold with a £2473.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Spark’s Take on GB:CRW Stock
According to Spark, TipRanks’ AI Analyst, GB:CRW is a Neutral.
Craneware’s overall stock score is driven primarily by its strong financial performance, characterized by revenue growth and a solid balance sheet. However, the high P/E ratio suggests potential overvaluation, and technical indicators show a neutral trend with no strong momentum. The absence of earnings call insights and corporate events leaves these areas unaddressed in the analysis.
To see Spark’s full report on GB:CRW stock, click here.
More about Craneware
Craneware plc is a leader in healthcare financial and operational transformation, offering advanced technologies through its Trisus cloud ecosystem. The company focuses on optimizing performance and financial sustainability for healthcare organizations, providing solutions that simplify healthcare finance and operations. Craneware is recognized for its deep healthcare expertise and engineering excellence, positioning itself as a strategic partner in the industry.
Average Trading Volume: 132,521
Technical Sentiment Signal: Buy
Current Market Cap: £801.9M
Find detailed analytics on CRW stock on TipRanks’ Stock Analysis page.